DK: Jeg har 25 års erfaring i cancer immunologi og immunterapi, har en ph.d. i basal cancer immunologi og et professorat i klinisk cancer immunterapi. Leder af det translationelle forskningscenter Center for Cancer Immunterapi (CCIT), Herlev Universitetshospital. CCIT arbejder translationelt og har bred erfaring med præklinisk forskning såvel som kliniske studier af egne eksperimentelle immunterapier. Siden 2005 har CCIT gennemført adskillige kliniske forsøg med behandling af over 200 patienter. Det er et mål for CCIT at udvikle immunterapi til et bredt spektrum af kræftpatienter, og der er således gennemført kliniske studier indenfor både myelomatose, myeloproliferative neoplasier, modermærke-, lunge-, nyre-, bryst-, ovarie- og prostatakræft.

UK: I have 25 years of experience in cancer immunology and immunotherapy, a PhD in basic cancer immunology and a professorship in clinical cancer immunotherapy. I am the leader of the translational research center National Center for Cancer Immune Therapy (CCIT), Herlev University Hospital. CCIT works translational and has a broad experience with pre-clinical research as well as clinical studies of own experimental immunotherapies. Since 2005, CCIT has completed several clinical trials with the treatment of over 200 patients. It is a goal for CCIT to develop immunotherapy to a broad spectrum of cancer patients. Accordingly, clinical studies have been completed within myelomatosis, myeloproliferative Neoplasms, birthmark-, lung, kidney, breast, ovary- and prostate cancer.